NKTR Earnings Nektar Therapeutics
Reported diluted EPS by fiscal period (SEC EDGAR). Chart & overview →
1–20 of 20
| Q1 2026 | 2026-03-31 | -1.82 | 2026-05-08 | 10-Q |
| FY 2025 | 2025-12-31 | -9.73 | 2026-03-13 | 10-K |
| Q3 2025 | 2025-09-30 | -8.14 | 2025-11-07 | 10-Q |
| Q2 2025 | 2025-06-30 | -6.57 | 2025-08-08 | 10-Q |
| Q1 2026 | 2025-03-31 | -3.62 | 2026-05-08 | 10-Q |
| FY 2025 | 2024-12-31 | -8.68 | 2026-03-13 | 10-K |
| Q3 2025 | 2024-09-30 | -9.27 | 2025-11-07 | 10-Q |
| Q2 2025 | 2024-06-30 | -6.63 | 2025-08-08 | 10-Q |
| Q1 2025 | 2024-03-31 | -0.19 | 2025-05-09 | 10-Q |
| FY 2024 | 2023-12-31 | -1.45 | 2025-03-14 | 10-K |
| Q3 2024 | 2023-09-30 | -1.23 | 2024-11-08 | 10-Q |
| Q2 2024 | 2023-06-30 | -0.99 | 2024-08-09 | 10-Q |
| Q1 2024 | 2023-03-31 | -0.73 | 2024-05-10 | 10-Q |
| FY 2023 | 2022-12-31 | -1.97 | 2024-03-05 | 10-K |
| Q3 2023 | 2022-09-30 | -1.65 | 2023-11-08 | 10-Q |
| Q2 2023 | 2022-06-30 | -1.34 | 2023-08-09 | 10-Q |
| Q1 2023 | 2022-03-31 | -0.49 | 2023-05-10 | 10-Q |
| FY 2023 | 2021-12-31 | -2.86 | 2024-03-05 | 10-K |
| Q3 2022 | 2021-09-30 | -2.07 | 2022-11-04 | 10-Q |
| Q2 2022 | 2021-06-30 | -1.37 | 2022-08-05 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Informational only — not financial advice.